Evidence map›Paper›PMID 41067724›Full record

ArticleBone & joint open2025

No benefit in biomarkers assessing muscle damage for minimally invasive anterior over SPAIRE approach in hemiarthroplasty : a subgroup analysis with 100 patients from a randomized controlled trial.

Stein H Ugland, Oystein T Fagerberg, Knut E Mjaaland, Terje O Ugland, Glen Haugeberg, Are H Pripp, Lars Nordsletten

Abstract read
In one paragraph

Article in Bone & joint open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stein H UglandDepartment of Orthopaedics, Sorlandet Hospital, Kristiansand, Norway.
Oystein T FagerbergDepartment of Orthopaedics, Sorlandet Hospital, Kristiansand, Norway.
Knut E MjaalandDepartment of Orthopaedics, Sorlandet Hospital, Arendal, Norway.
Terje O UglandDepartment of Orthopaedics, Sorlandet Hospital, Kristiansand, Norway.
Glen HaugebergDepartment of Neurosciences, Rheumatology Division, Norwegian University of Science and Technology, Trondheim, Norway.
Are H PrippOslo University Hospital and Oslo Metropolitan University, Oslo, Norway.
Lars NordslettenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Muscle damage and inflammation after hemiarthroplasty (HA) for femoral neck fracture (FNF) could affect time to mobilization. Early mobilization is key in enhanced recovery and fast-track care systems. We have compared muscle damage and inflammation using creatine kinase (CK) and CRP as biomarkers in FNF patients operated on with the direct anterior (DA) and the sparing piriformis and obturator internus, repairing externus (SPAIRE) approach. Methods: From January 2022, 158 eligible patients with a dislocated FNF were included in a randomized controlled trial comparing the approaches (n = 158). Hypothesis and planned statistical tests were pre-specified in this sub-group analysis and 100 patients were tested for CK, CRP, and haemoglobin (Hb) levels during hospital admission. Results: Mean difference in CK between groups was, on postoperative day one, 45 u/l (95% CI -22 to 151, p = 0.290) and day two, 66 U/l (95% CI -42 to 185, p = 0.19). Mean difference in CRP was 3 mg/l (95% CI -23 to 19, p = 0.933) and Hb, 0.3 g/dl (95% CI -0.2 to 0.5, p = 0.388) on day two postoperatively. No correlation was found between CK/CRP and Timed Up and Go test and Harris Hip Score. Conclusion: There were no differences in CK and CRP changes between the groups on day one and two after surgery. No correlation was found between CK and clinical outcomes in FNF patients operated with SPAIRE and the DA approach.

Identifiers

PMID41067724
PMCPMC12516294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.